BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 24622760)

  • 1. The role of the complement system in age-related macular degeneration.
    Weber BH; Charbel Issa P; Pauly D; Herrmann P; Grassmann F; Holz FG
    Dtsch Arztebl Int; 2014 Feb; 111(8):133-8. PubMed ID: 24622760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Polymorphisms of complement factor genes and age-related macular degeneration in a German population].
    Baatz H; Poupel L; Coudert M; Sennlaub F; Combadiere C
    Klin Monbl Augenheilkd; 2009 Aug; 226(8):654-8. PubMed ID: 19399715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In reply.
    Bernhard HF; Holz FG
    Dtsch Arztebl Int; 2014 May; 111(20):366. PubMed ID: 24882633
    [No Abstract]   [Full Text] [Related]  

  • 4. Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation.
    Proitsi P; Lupton MK; Dudbridge F; Tsolaki M; Hamilton G; Daniilidou M; Pritchard M; Lord K; Martin BM; Johnson J; Craig D; Todd S; McGuinness B; Hollingworth P; Harold D; Kloszewska I; Soininen H; Mecocci P; Velas B; Gill M; Lawlor B; Rubinsztein DC; Brayne C; Passmore PA; Williams J; Lovestone S; Powell JF
    Neurobiol Aging; 2012 Aug; 33(8):1843.e9-17. PubMed ID: 22300950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA plays an important role.
    Uebermuth C
    Dtsch Arztebl Int; 2014 May; 111(20):366. PubMed ID: 24882632
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic Risk, Lifestyle, and Age-Related Macular Degeneration in Europe: The EYE-RISK Consortium.
    Colijn JM; Meester-Smoor M; Verzijden T; de Breuk A; Silva R; Merle BMJ; Cougnard-Grégoire A; Hoyng CB; Fauser S; Coolen A; Creuzot-Garcher C; Hense HW; Ueffing M; Delcourt C; den Hollander AI; Klaver CCW;
    Ophthalmology; 2021 Jul; 128(7):1039-1049. PubMed ID: 33253757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment.
    Geerlings MJ; de Jong EK; den Hollander AI
    Mol Immunol; 2017 Apr; 84():65-76. PubMed ID: 27939104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide association studies: getting to pathogenesis, the role of inflammation/complement in age-related macular degeneration.
    Cooke Bailey JN; Pericak-Vance MA; Haines JL
    Cold Spring Harb Perspect Med; 2014 Sep; 4(12):a017186. PubMed ID: 25213188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal function and CFH-ARMS2 polymorphisms analysis: a pilot study in Italian AMD patients.
    Capoluongo E; Concolino P; Piccardi M; Marangoni D; Mello E; Minnella AM; Savastano C; Fadda A; Zuppi C; Bisti S; Falsini B
    Neurobiol Aging; 2012 Aug; 33(8):1852.e5-12. PubMed ID: 22552255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement Component C3 Variant (R102G) and the Risk of Neovascular Age-Related Macular Degeneration in a Tunisian Population.
    Habibi I; Sfar I; Kort F; Bouraoui R; Chebil A; Limaiem R; Ayed S; Ben Abdallah T; El Matri L; Gorgi Y
    Klin Monbl Augenheilkd; 2017 Apr; 234(4):478-482. PubMed ID: 28470643
    [No Abstract]   [Full Text] [Related]  

  • 11. Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration.
    van de Ven JP; Smailhodzic D; Boon CJ; Fauser S; Groenewoud JM; Chong NV; Hoyng CB; Klevering BJ; den Hollander AI
    Mol Vis; 2012; 18():2271-8. PubMed ID: 22933840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
    Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels.
    Ristau T; Paun C; Ersoy L; Hahn M; Lechanteur Y; Hoyng C; de Jong EK; Daha MR; Kirchhof B; den Hollander AI; Fauser S
    PLoS One; 2014; 9(3):e93459. PubMed ID: 24675670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of age-related macular degeneration associated genetic risk factors and 4-year progression data in the Irish population.
    Connolly E; Rhatigan M; O'Halloran AM; Muldrew KA; Chakravarthy U; Cahill M; Kenny RA; Doyle SL
    Br J Ophthalmol; 2018 Dec; 102(12):1691-1695. PubMed ID: 29453225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARMS2 increases the risk of early and late age-related macular degeneration in the European Eye Study.
    Chakravarthy U; McKay GJ; de Jong PT; Rahu M; Seland J; Soubrane G; Tomazzoli L; Topouzis F; Vingerling JR; Vioque J; Young IS; Sofat R; Hingorani AD; Fletcher AE
    Ophthalmology; 2013 Feb; 120(2):342-8. PubMed ID: 23098369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement System and Age-Related Macular Degeneration: Implications of Gene-Environment Interaction for Preventive and Personalized Medicine.
    Maugeri A; Barchitta M; Mazzone MG; Giuliano F; Agodi A
    Biomed Res Int; 2018; 2018():7532507. PubMed ID: 30225264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration.
    Hageman GS; Gehrs K; Lejnine S; Bansal AT; Deangelis MM; Guymer RH; Baird PN; Allikmets R; Deciu C; Oeth P; Perlee LT
    Hum Genomics; 2011 Jul; 5(5):420-40. PubMed ID: 21807600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genetic approach to stratification of risk for age-related macular degeneration.
    Zanke B; Hawken S; Carter R; Chow D
    Can J Ophthalmol; 2010 Feb; 45(1):22-7. PubMed ID: 20130705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validated Prediction Models for Macular Degeneration Progression and Predictors of Visual Acuity Loss Identify High-Risk Individuals.
    Seddon JM; Rosner B
    Am J Ophthalmol; 2019 Feb; 198():223-261. PubMed ID: 30389371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.
    Despriet DD; Klaver CC; Witteman JC; Bergen AA; Kardys I; de Maat MP; Boekhoorn SS; Vingerling JR; Hofman A; Oostra BA; Uitterlinden AG; Stijnen T; van Duijn CM; de Jong PT
    JAMA; 2006 Jul; 296(3):301-9. PubMed ID: 16849663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.